| 2024-04-01 | Sale | Repare Therapeutics Inc. RPTX | EVP, CHIEF FINANCIAL OFFICER | 789 0.0018% | $4.61 | $3,637 | -25.11% | |
| 2024-03-28 | Sale | Repare Therapeutics Inc. RPTX | EVP, CHIEF FINANCIAL OFFICER | 825 0.0019% | $4.62 | $3,812 | -25.16% | |
| 2024-03-27 | Sale | Repare Therapeutics Inc. RPTX | EVP, CHIEF FINANCIAL OFFICER | 825 0.0019% | $4.62 | $3,812 | -24.41% | |
| 2024-03-26 | Sale | Repare Therapeutics Inc. RPTX | EVP, CHIEF FINANCIAL OFFICER | 825 0.002% | $4.60 | $3,795 | -22.08% | |
| 2024-03-25 | Sale | Repare Therapeutics Inc. RPTX | EVP, CHIEF FINANCIAL OFFICER | 825 0.002% | $4.79 | $3,952 | -25.84% | |
| 2020-06-23 | Repare Therapeutics Inc. RPTX | EVP, Chief Financial Officer | 10,000 0.1258% | $20.00 | $200,000 | -4.43% |